Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-01-13 @ 7:54 AM
Study NCT ID:
NCT04072458
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-24
First Post:
2019-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies
Sponsor:
Bio-Path Holdings, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Mantle Cell Lymphoma | View |
| None | Peripheral T-cell Lymphoma (PTCL) | View |
| None | Cutaneous T-cell Lymphoma (CTCL) | View |
| None | Chronic Lymphocytic Leukemia (CLL) | View |
| None | Small Lymphocytic Lymphoma (SLL) | View |
| None | Follicular Lymphoma | View |
| None | Marginal Zone Lymphoma | View |
| None | Hodgkin Lymphoma | View |
| None | Waldenstrom Macroglobulinemia | View |
| None | DLBCL | View |
Keywords: